Skip Navigation
Johns Hopkins Medicine International
In This Section      
Print This Page

Neurology and Neurosurgery

The Departments of Neurology and Neurosurgery at Johns Hopkins improve the lives of patients by sharing ideas across disciplines and joining forces to develop the strongest individualized treatment plans—this is truly what sets Johns Hopkins apart from any other medical institution.

Our physicians are able to bring new and exceptional treatments to patients faster because of our tight network of experts. When our researchers make discoveries in the lab, they collaborate with our physicians to carefully translate them into the latest treatment options.

U.S. News & World Report consistently ranks The Johns Hopkins Hospital as having among the top neurology and neurosurgery programs in the country in its annual “America’s Best Hospitals” survey.

Patients come to Johns Hopkins from around the world to receive the most cutting-edge care, including treatment for:

To learn more or to make an appointment, call +1-410-614-4633.

Discover Our Research

Getting To The Root Of Parkinson's Disease
Working with human neurons and fruit flies, researchers at Johns Hopkins have identified and then shut down a biological process that appears to trigger a particular form of Parkinson’s disease present in a large number of patients. A report on the study, in the April 10 issue of the journal Cell, could lead to new treatments for this disorder.  Learn more.

Researchers Identify Gene That Helps Fruit Flies Go to Sleep
In a series of experiments sparked by fruit flies that couldn’t sleep, Johns Hopkins researchers say they have identified a mutant gene — dubbed “Wide Awake” — that sabotages how the biological clock sets the timing for sleep. The finding also led them to the protein made by a normal copy of the gene that promotes sleep early in the night and properly regulates sleep cycles.  Learn more.

Johns Hopkins Researchers Erase Human Brain Tumor Cells in Mice
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of — and ultimately left no detectable trace of — brain tumor cells taken from adult human patients. Learn more about this breakthrough.

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.